Estradiol valerate and tibolone : Effects on memoryDE AGUIAR, R. B; DICKEL, O. E; CUNHA, R. W et al.Pharmacology, biochemistry and behavior. 2006, Vol 85, Num 4, pp 689-696, issn 0091-3057, 8 p.Article

Hormone replacement therapy and vigilance: Double-blind, placebo-controlled EEG-mapping studies with an estrogen-progestogen combination (Climodien®, Lafamme®) versus estrogen alone in menopausal syndrome patientsSALETU, Bernd; ANDERER, Peter; GRUBER, Doris et al.Maturitas (Amsterdam). 2002, Vol 43, Num 3, pp 165-181, issn 0378-5122, 17 p.Article

Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label studyENDRIKAT, Jan; PARKE, Susanne; TRUMMER, Dietmar et al.Contraception (Stoneham). 2013, Vol 87, Num 2, pp 227-234, issn 0010-7824, 8 p.Article

Pharmacokinetics of estradiol valerate and medroxyprogesterone acetate in different age groups of postmenopausal womenJÄRVINEN, Asko; KAINULAINEN, Petri; NISSILÄ, Minna et al.Maturitas (Amsterdam). 2004, Vol 47, Num 3, pp 209-217, issn 0378-5122, 9 p.Article

LE MÉDICAMENT DU MOIS Nouvelle contraception orale combinée au valérate d'estradiol et au diénogest (Qlaira^®) = A NEW COMBINED ORAL CONTRACEPTIVE CONTAINING ESTRADIOL VALERATE AND DIENOGEST (QLAIRA^®)GASPARD, U; PINTIAUX, A; KRIDELKA, F et al.RMLG. Revue médicale de Liège. 2010, Vol 65, Num 12, issn 0370-629X, 706-713 [8 p.]Article

Effect of estradiol valerate and levonorgestrel on vaginal healthMANONAI, Jittima; CHITTACHAROEN, Apichart; THEPPISAI, Urusa et al.European journal of obstetrics, gynecology, and reproductive biology. 2004, Vol 115, Num 2, pp 190-193, issn 0301-2115, 4 p.Article

Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolismDE LEO, Vincenzo; FRUZZETTI, Franca; MUSACCHIO, Maria Concetta et al.Contraception (Stoneham). 2013, Vol 88, Num 3, pp 364-368, issn 0010-7824, 5 p.Article

Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive : results of two prospective, randomized, open-label studiesENDRIKAT, Jan; PARKE, Susanne; TRUMMER, Dietmar et al.Contraception (Stoneham). 2008, Vol 78, Num 3, pp 218-225, issn 0010-7824, 8 p.Article

Simultaneous spectrophotometric determination of cyproterone acetate and estradiol valerate in pharmaceutical preparations by ratio spectra derivative and chemometric methodsDINC, Erdal; YÜCESOY, Cem; PALABIYIK, I. Murat et al.Journal of pharmaceutical and biomedical analysis. 2003, Vol 32, Num 3, pp 539-547, issn 0731-7085, 9 p.Article

Efficacy and tolerability of the hormone replacement drug estradiol valerate/levonorgestrel in the treatment of menopausal syndrome in Thai womenCHITTACHAROEN, A; DOMHARDT, R; MANONAI, J et al.Methods and findings in experimental and clinical pharmacology. 2003, Vol 25, Num 8, pp 645-651, issn 0379-0355, 7 p.Article

Effect of four oral contraceptives on hemostatic parametersWIEGRATZ, I; LEE, J. H; KUTSCHERA, E et al.Contraception (Stoneham). 2004, Vol 70, Num 2, pp 97-106, issn 0010-7824, 10 p.Article

Identifying target regions for vigilance improvement under hormone replacement therapy in postmenopausal syndrome patients by means of electroencephalographic tomography (LORETA)SALETU, B; ANDERER, P; SALETU-ZYHLARZ, G. M et al.Psychopharmacologia. 2005, Vol 178, Num 4, pp 389-399, issn 0033-3158, 11 p.Article

Estradiol valerate and intake of sweetened waterBOSWELL, Karen J; REID, Meta L; FITCH, Jessic V et al.Pharmacology, biochemistry and behavior. 2005, Vol 80, Num 1, pp 1-7, issn 0091-3057, 7 p.Article

Review of clinical experience with estradiol in combined oral contraceptivesFRUZZETTI, Franca; BITZER, Johannes.Contraception (Stoneham). 2010, Vol 81, Num 1, pp 8-15, issn 0010-7824, 8 p.Article

Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrelAHRENDT, Hans-Joachim; MAKALOVA, Dagmar; PARKE, Susanne et al.Contraception (Stoneham). 2009, Vol 80, Num 5, pp 436-444, issn 0010-7824, 9 p.Article

Estradiol Valerate/Dienogest: A Novel Oral ContraceptiveWHALEN, Karen L; ROSE, Renee.The Annals of pharmacotherapy. 2011, Vol 45, Num 10, pp 1256-1261, issn 1060-0280, 6 p.Article

Estradiol Valerate/Dienogest: A Novel Combined Oral ContraceptiveBORGELT, Laura M; MARTELL, Chad W.Clinical therapeutics. 2012, Vol 34, Num 1, pp 37-55, issn 0149-2918, 19 p.Article

Effective Treatment of Heavy Menstrual Bleeding With Estradiol Valerate and Dienogest: A Randomized Controlled TrialJENSEN, Jeffrey T; PARKE, Susanne; MELLINGER, Uwe et al.Obstetrics and gynecology (New York. 1953). 2011, Vol 117, Num 4, pp 777-787, issn 0029-7844, 11 p.Article

Estradiol valerate as a possible endocrine reproductive disruptor : evidence from an in vivo rat modelSEIDMAN, Daniel S; ITSEKSON, Alek; ALESKER, Michael et al.Fertility and sterility. 2009, Vol 91, Num 4, pp 1510-1512, issn 0015-0282, 3 p., SUPArticle

Development and Validation of Spectrophotometric and High-Performance Column Liquid Chromatographic Methods for the Simultaneous Determination of Dienogest and Estradiol Valerate in Pharmaceutical PreparationsCAGLAYAN, Mehmet Gokhan; PALABIYIK, Ismail Murat; ONUR, Feyyaz et al.Journal of AOAC International. 2010, Vol 93, Num 3, pp 862-868, issn 1060-3271, 7 p.Article

CURRENT STATUS OF ESTROGEN THERAPY FOR THE MENOPAUSEHAMMOND CB; MAXON WS.1982; FERTIL. STERIL.; ISSN 0015-0282; USA; DA. 1982; VOL. 37; NO 1; PP. 5-25; BIBL. 184 REF.Article

PHARMACOKINETIC AND PHARMACOLOGICAL FEATURES OF OESTRADIOL VALERATEDUESTERBERG B; NISHINO Y.1982; MATURITAS; ISSN 0378-5122; NLD; DA. 1982; VOL. 4; NO 4; PP. 315-324; BIBL. 32 REF.Article

High-performance liquid chromatographic analysis of estradiol valerate-testosterone enanthate in oily formulationsCARIGNAN, G; LODGE, B. A; SKAKUM, W et al.Journal of chromatography. 1984, Vol 301, Num 1, pp 292-296, issn 0021-9673Article

A multicenter, prospective, randomized, double-blind, placebo-controlled study to investigate the efficacy of a continuous-combined hormone therapy preparation containing 1 mg estradiol valerate/2 mg dienogest on hot flushes in postmenopausal womenENDRIKAT, Jan; GRAESER, Thomas; MELLINGER, Uwe et al.Maturitas (Amsterdam). 2007, Vol 58, Num 2, pp 201-207, issn 0378-5122, 7 p.Article

Molecular and pharmacodynamic properties of estrogenic extracts from the traditional Chinese medicinal herb, EpimediumYAP, S. P; SHEN, P; LI, J et al.Journal of ethnopharmacology. 2007, Vol 113, Num 2, pp 218-224, issn 0378-8741, 7 p.Article